Form 8-K - Current report:
SEC Accession No. 0001437749-25-009351
Filing Date
2025-03-26
Accepted
2025-03-26 16:06:16
Documents
16
Period of Report
2025-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20240925_8k.htm   iXBRL 8-K 28413
2 EXHIBIT 99.1 ex_727220.htm EX-99.1 151038
7 dyadic.jpg GRAPHIC 4271
  Complete submission text file 0001437749-25-009351.txt   341555

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20250326.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20250326_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20250326_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20250326_pre.xml EX-101.PRE 11584
18 EXTRACTED XBRL INSTANCE DOCUMENT dyai20240925_8k_htm.xml XML 2850
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 25773190
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)